Výsledky vyhledávání - Ludger Große‐Hovest
- Zobrazuji výsledky 1 - 7 z 7
-
1
-
2
γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity Assay Autor Ursula Jördis Eva Seidel, Fabian Vogt, Ludger Große‐Hovest, Gundram Jung, Rupert Handgretinger, Peter Lang
Vydáno 2014Artigo -
3
-
4
Characterization of a Bispecific FLT3 X CD3 Antibody in an Improved, Recombinant Format for the Treatment of Leukemia Autor Michael Durben, Dominik Schmiedel, Martin Hofmann, Fabian Vogt, T Nübling, Elwira Pyż, Hans‐Jörg Bühring, Hans‐Georg Rammensee, Helmut R. Salih, Ludger Große‐Hovest, Gundram Jung
Vydáno 2015Artigo -
5
RANKL Expression, Function, and Therapeutic Targeting in Multiple Myeloma and Chronic Lymphocytic Leukemia Autor Benjamin Joachim Schmiedel, Carolin Andrea Scheible, Tina Nuebling, Hans‐Georg Kopp, Stefan Wirths, Miyuki Azuma, Pascal Schneider, Gundram Jung, Ludger Große‐Hovest, Helmut R. Salih
Vydáno 2012Artigo -
6
Genetically engineered CAR NK cells display selective cytotoxicity against FLT3‐positive B‐ALL and inhibit <i>in vivo</i> leukemia growth Autor Sarah Oelsner, Anja Waldmann, Arne Billmeier, Jasmin Röder, Aline Lindner, Evelyn Ullrich, Rolf Marschalek, Gianpietro Dotti, Gundram Jung, Ludger Große‐Hovest, Pranav Oberoi, Peter Bader, Winfried S. Wels
Vydáno 2019Artigo -
7
Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody Autor Adalbert Krawczyk, Michaela A.E. Arndt, Ludger Große‐Hovest, Wilko Weichert, Bernd Giebel, Ulf Dittmer, Hartmut Hengel, Dirk Jäger, Karl E. Schneweis, Anna Maria Eis‐Hübinger, Michael Roggendorf, Jürgen Krauß
Vydáno 2013Artigo
Vyhledávací nástroje:
Související témata
Biology
Immunology
Biochemistry
Cancer research
Immune system
Antibody
Chemistry
Cytotoxicity
In vitro
Leukemia
Monoclonal antibody
Antigen
CD3
CD8
Cell biology
Medicine
Molecular biology
Receptor
Virology
Activator (genetics)
Adoptive cell transfer
Antibody-dependent cell-mediated cytotoxicity
Antiviral drug
Bispecific antibody
CD16
Chimeric antigen receptor
Cytokine
Cytolysis
Denosumab
Drug resistance